Filgotinib: Phase IIb final data

Final data from the double-blind, international Phase IIb DARWIN 1 trial in 594 patients with moderate to severe RA who had an inadequate response to methotrexate showed that once-daily 200 mg and twice-daily 100 mg filgotinib as an add-on to methotrexate each significantly improved ACR20 response rate at week

Read the full 490 word article

How to gain access

Continue reading with a
two-week free trial.